Biological

Vascular endothelial growth factor receptor 2 clinical trials

studies test it: 6
open now: 0
in phase 3: 0
first study started: 2007

How studies write it

Studies that test it under each name

Combined with it in one product

VEGFR1 and VEGFR2: 3
VEGFR1: 1
VEGFR2: 1
AMD: 1
LY6K, VEGFR1, VEGFR2: 1
UFT: 1
UZEL: 1
VEGFR1, VEGFR2: 1

Studies by the year they started

6 studies that test it; most in 2008 (4)

Studies that test vascular endothelial growth factor receptor 2, by start year
Year	Studies
2007	1
2008	4
2020	1

By phase

A phase 1/2 study counts in both.

Phase 1: 5
Phase 2: 2
No phase: 1

What it is tested for

Each study’s main condition, where its own words name it.

Carcinoma, Renal Cell: 1
Macular Degeneration: 1
Esophageal Neoplasms: 1
Breast Neoplasms: 1
Colorectal Neoplasms: 1
Pancreatic Neoplasms: 1

Who runs them

Industry 0 · Other 6

Tokyo University (2) · Stanford University (1) · Osaka University (1) · Japanese Foundation for Cancer Research (1) · Fukushima Medical University (1)

Often tested with

Tested in the same studies.

Vascular endothelial growth factor receptor 1 (5) · Lymphocyte Antigen 6K (1) · Gemcitabine (1)

Studies

Open first, then newest update. How each study uses vascular endothelial growth factor receptor 2 is read from its arms, and is right about nine times in ten.